Englander Institute for Precision Medicine
Found 797 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2021
Gjyrezi A, Galletti G, Zhang J, Worroll D, Sigouros M, Kim S, Cooley V, Ballman KV, Ocean AJ, Shah MA et al..  2021.  Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage.. Commun Biol. 4(1):785.
Skaro M, Hill M, Zhou Y, Quinn S, Davis MB, Sboner A, Murph M, Arnold J.  2021.  Are we there yet? A machine learning architecture to predict organotropic metastases. BMC Med Genomics. 14(1):281.
Bhinder B, Gilvary C, Madhukar NS, Elemento O.  2021.  Artificial Intelligence in Cancer Research and Precision Medicine.. Cancer Discov. 11(4):900-915.
Elemento O, Leslie C, Lundin J, Tourassi G.  2021.  Artificial intelligence in cancer research, diagnosis and therapy.. Nat Rev Cancer. 21(12):747-752.
Kepp O, Bezu L, Yamazaki T, Di Virgilio F, Smyth MJ, Kroemer G, Galluzzi L.  2021.  ATP and cancer immunosurveillance.. EMBO J. 40(13):e108130.
Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P, San Pedro JManuel Bra, Cadwell K, Cecconi F, Choi AMK et al..  2021.  Autophagy in major human diseases.. EMBO J. 40(19):e108863.
Yamazaki T, San Pedro JManuel Bra, Galluzzi L, Kroemer G, Pietrocola F.  2021.  Autophagy in the cancer-immunity dialogue.. Adv Drug Deliv Rev. 169:40-50.
Grivas P, Agarwal N, Pal S, Kalebasty ARezazadeh, Sridhar SS, Smith J, Devgan G, Sternberg CN, Bellmunt J.  2021.  Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice.. Cancer Treat Rev. 97:102187.
Powles T, Sridhar SS, Loriot Y, Bellmunt J, Mu XJasmine, Ching KA, Pu J, Sternberg CN, Petrylak DP, Tambaro R et al..  2021.  Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial.. Nat Med. 27(12):2200-2211.
de Wit R, Wülfing C, Castellano D, Kramer G, Eymard J-C, Sternberg CN, Fizazi K, Tombal B, Bamias A, Carles J et al..  2021.  Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study.. ESMO Open. 6(5):100241.
Cho BAngela, Iyengar NM, Zhou XKathy, Morrow M, Giri DD, Verma A, Elemento O, Pollak M, Dannenberg AJ.  2021.  Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome.. Carcinogenesis. 42(10):1281-1292.
Croker JA, Patel R, Campbell KS, Barton-Baxter M, Wallet S, Firestein GS, Kimberly RP, Elemento O.  2021.  Building biorepositories in the midst of a pandemic.. J Clin Transl Sci. 5(1):e92.
Suzuki H, Castellano D, de Bono J, Sternberg CN, Fizazi K, Tombal B, Wülfing C, Foster MC, Ozatilgan A, Geffriaud-Ricouard C et al..  2021.  Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.. Jpn J Clin Oncol. 51(8):1287-1297.
Fucikova J, Spisek R, Kroemer G, Galluzzi L.  2021.  Calreticulin and cancer.. Cell Res. 31(1):5-16.
Bourdenx M, Martín-Segura A, Scrivo A, Rodriguez-Navarro JA, Kaushik S, Tasset I, Diaz A, Storm NJ, Xin Q, Juste YR et al..  2021.  Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome.. Cell. 184(10):2696-2714.e25.
Bruno NE, Nwachukwu JC, Srinivasan S, Nettles CC, Izard T, Jin Z, Nowak J, Cameron MD, Boregowda SV, Phinney DG et al..  2021.  Chemical systems biology reveals mechanisms of glucocorticoid receptor signaling.. Nat Chem Biol. 17(3):307-316.
Bekheirnia N, Glinton KE, Rossetti L, Manor J, Chen W, Lamb DJ, Braun MC, Bekheirnia MReza.  2021.  Clinical Utility of Genetic Testing in the Precision Diagnosis and Management of Pediatric Patients with Kidney and Urinary Tract Diseases.. Kidney360. 2(1):90-104.
Rivas MA, Durmaz C, Kloetgen A, Chin CR, Chen Z, Bhinder B, Koren A, Viny AD, Scharer CD, Boss JM et al..  2021.  Cohesin Core Complex Gene Dosage Contributes to Germinal Center Derived Lymphoma Phenotypes and Outcomes.. Front Immunol. 12:688493.
Bauer A, Zierer A, Gieger C, Buyukozkan M, Müller-Nurasyid M, Grallert H, Meisinger C, Strauch K, Prokisch H, Roden M et al..  2021.  Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study.. Genet Epidemiol. 45(6):633-650.
De Giorgi U, Hussain M, Shore N, Fizazi K, Tombal B, Penson D, Saad F, Efstathiou E, Madziarska K, Steinberg J et al..  2021.  Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and region.. Eur J Cancer. 159:237-246.
Meleshko D, Hajirasouliha I, Korobeynikov A.  2021.  coronaSPAdes: from biosynthetic gene clusters to RNA viral assemblies.. Bioinformatics. 38(1):1-8.
Punjani N, Kang C, Lamb DJ.  2021.  Current updates and future perspectives in the evaluation of azoospermia: A systematic review.. Arab J Urol. 19(3):206-214.
Oudard S, Benhamouda N, Escudier B, Ravel P, Tran T, Levionnois E, Negrier S, Barthelemy P, Berdah JFrançois, Gross-Goupil M et al..  2021.  Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.. Cells. 11(1)
Khosravi P, Lysandrou M, Eljalby M, Li Q, Kazemi E, Zisimopoulos P, Sigaras A, Brendel M, Barnes J, Ricketts C et al..  2021.  A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion.. J Magn Reson Imaging. 54(2):462-471.
Xu Z, Verma A, Naveed U, Bakhoum SF, Khosravi P, Elemento O.  2021.  Deep learning predicts chromosomal instability from histopathology images.. iScience. 24(5):102394.